← Back to Search

Comprehensive Care Approach for High Cholesterol (CARE-FH Trial)

N/A

Waitlist Available

Led By Laney K Jones, PharmD, MPH

Research Sponsored by Geisinger Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 9, 12, 18, 24, 30, 36, 42

Awards & highlights

No Placebo-Only Group

Summary

This trialwill use implementation science to improve diagnosis and treatment of high cholesterol, to prevent heart attacks in people with familial hypercholesterolemia. It could help other health care systems improve diagnosis rates.

Who is the study for?

This trial is for primary care clinicians within the Geisinger Healthcare System. It aims to involve doctors who practice in pediatrics, community medicine, or internal medicine. There are no specific exclusion criteria mentioned, so it appears open to all clinicians in these fields.

What is being tested?

The CARE-FH trial is testing a series of strategies designed to improve diagnosis rates of familial hypercholesterolemia (FH) in primary care settings. These include educational materials and outreach, quality monitoring tools, interventions with clinicians and patients, identifying clinical champions for lipids management, and providing feedback on performance.

What are the potential side effects?

Since this trial focuses on implementation strategies rather than medical treatments or drugs, there are no traditional side effects associated with participation. However, participants may experience changes in clinic workflow or increased workload due to the new diagnostic programs.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 9, 12, 18, 24, 30, 36, 42

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 9, 12, 18, 24, 30, 36, 42

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 9, 12, 18, 24, 30, 36, 42 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability (Aim 3)

FH diagnosis rate (Aim 2)

Timeliness (Aim 4)

Secondary study objectives

Best Practice Alert (Aim 2)

Cost (Aim 3)

FH Clinic Note (Aim 2)

+7 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.